Document Detail

Infiltrating CD57+ Inflammatory Cells in Head and Neck Squamous Cell Carcinoma: Clinicopathological Analysis and Prognostic Significance.
MedLine Citation:
PMID:  22505010     Owner:  NLM     Status:  In-Data-Review    
This study investigated the immunodetection of CD57 inflammatory cells in patients with head and neck squamous cell carcinoma (HNSCC) and its association with clinicopathological parameters and overall survival. Data collected from the morphological analysis and immunohistochemical reaction testing of archived HNSCC specimens (n=70) were statistically analyzed by bivariate and multivariate statistical testing at a significance level of P<0.05. The results indicate that CD57 inflammatory cells predominate within the peritumoral stroma of HNSCC lesions and the existence of two significant relationships: between high CD57 cell density and the development of a tumor of a large size [odds ratio (OR)=5.610, 95% confidence interval (CI)=1.516-20.763) and between high CD57 cell density and the development of locoregional metastatic disease (OR=3.401, 95% CI=1.162-9.951). A significant difference in the rate of survival was detected only in HNSCC patients that presented large size tumors (OR=4.747, 95% CI=1.281-17.594). Together, these results suggest that although high CD57 inflammatory cell density is associated with HNSCC lesions of greater clinical severity, the variable of cell density is not an independent predictor of HNSCC patient survival. Our findings also suggest that the relatively aggressive infiltration of CD57 inflammatory cells in the peritumoral stroma of head and neck carcinomas may contribute to an ineffective locoregional antitumoral response.
Carlos Alberto de Carvalho Fraga; Marcos Vinícius Macedo de Oliveira; Patrícia Luciana Batista Domingos; Ana Cristina de Carvalho Botelho; André Luiz Sena Guimarães; Andréa Teixeira-Carvalho; Rodrigo Correa-Oliveira; Alfredo Maurício Batista De Paula
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry     Volume:  20     ISSN:  1533-4058     ISO Abbreviation:  Appl. Immunohistochem. Mol. Morphol.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888796     Medline TA:  Appl Immunohistochem Mol Morphol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  285-90     Citation Subset:  IM    
*Health Science Programme, Health Research Laboratory, Universidade Estadual de Montes Claros, Montes Claros †Health Science Programme, Laboratory of Molecular and Cellular Immunology, Laboratory of Biomarkers for Diagnosis and Monitoring, Centro de Pesquisas René Rachou, Belo Horizonte, MG, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibin-a immunoreactivity in nervous system lesions.
Next Document:  Immunohistochemical comparative analysis of cell proliferation and angiogenic index in squamous cell...